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Active Bacterial Core Surveillance (ABCs) Report
 
Emerging Infections Program Network
 
Neisseria meningitidis, 2014
 
ABCs Areas 
California (3 county San Francisco Bay area); Colorado (5 
county Denver area); Connecticut; Georgia; Maryland; 
Minnesota; New Mexico; New York (15 county Rochester 
and Albany areas); Oregon; Tennessee (20 counties) 
ABCs Population 
The surveillance areas represent 43,528,246 persons. 
Source: National Center for Health Statistics bridged-race 
vintage 2014 postcensal file 
ABCs Case Definition 
Meningococcal disease: isolation of Neisseria 
meningitidis from normally sterile site in a resident of a 
surveillance area in 2014. 
ABCs Methodology 
ABCs personnel routinely contacted all microbiology 
laboratories serving acute care hospitals in their area to 
identify cases. Standardized case report forms that include 
information on demographic characteristics, clinical 
syndrome, and outcome of illness were completed for each 
identified case. Serogrouping of meningococcal isolates 
was done at CDC and state laboratories.  Regular 
laboratory audits assessed completeness of active 
surveillance and detected additional cases. 
All rates of meningococcal disease were calculated using 
population estimates for 2014 from the bridged-race 
vintage 2014 postcensal file. For national estimates of 
cases and deaths, race- and age-specific rates of disease 
were applied from the aggregate surveillance area to the 
age and racial distribution of the 2014 U.S. population for 
49 states (excluding Oregon due to an outbreak of 
serogroup B disease). The Oregon reported cases were 
then added to obtain the national estimates. Cases with 
missing data, excluding ethnicity, were multiply imputed 
using sequential regression imputation methods.¶  
Reported ABCs Profiles 
 
Race 
White 52 (0.16)
Black 13 (0.17)
Other 3 (0.09)
Total 68 (0.16)
* Per 100,000 population for ABCs areas
Cases Deaths
Syndrome No. (%*) No. (Rate†)
Meningitis 
Bacteremia without focus 
Percent of 
cases                                              
34   (50.0) 
13 (19.1)
2   (5.9) 
4   (30.8) 
† Per 100 cases with known outcome
¶ Surveillance Note
Missing race (n=5) data were multiply imputed using sequential regression
imputation methods.
Serogroups
Age 
 (years)
B 
  No.  (Rate*) 
C 
 No.  (Rate*) 
Y 
No. (Rate*)
Other‡  
  No. (Rate*) 
< 1 5 (1.03) 1 (0.21) 0 (0.00) 2 (0.41) 
1 1 (0.21) 2 (0.41) 0 (0.00) 0 (0.00) 
2-4 0 (0.00) 2 (0.14) 0 (0.00) 0 (0.00)
5-17 2 (0.03) 1 (0.01) 0 (0.00) 0 (0.00)
18-34 4 (0.04) 3 (0.03) 0 (0.00) 3 (0.03)
35-49 2 (0.03) 1 (0.01) 1 (0.01) 5 (0.06)
50-64 0 (0.00) 4 (0.05) 1 (0.01) 5 (0.06)
65-74 1 (0.03) 0 (0.00) 1 (0.03) 0 (0.00)
75-84 0 (0.00) 0 (0.00) 1 (0.06) 3 (0.19)
≥ 85 0 (0.00) 0 (0.00) 1 (0.14) 1 (0.14)
  15 (0.04)    5 (0.01)  19 (0.05) †  Total   14 (0.04)  
* Per 100,000 population for  ABCs areas excluding Oregon  
  
    
    
† Unknown serogroup (n=9) distributed amongst known. All rates 
exclude Oregon. Rates including Oregon are serogroup B 0.04, serogroup 
C 0.05, serogroup Y 0.02, and serogroup Other 0.04 per 100,000 
population for ABCs areas
‡ Other includes serogroup W and nongroupables 
Rates of Meningococcal Disease in Adolescents
and Young Adults†
Overall 
Serogroups 
    *   No.  (Rate ) 
C/Y/W Serogroups 
  *    No.  (Rate ) Age (years) 
11-17 2 (0.06) 1 (0.03) 
18-22 4 (0.15) 0 (0.00)
* Per 100,000 population for ABCs areas excluding Oregon 
† All rates exclude Oregon. Rates including Oregon are, for 11-17 year
olds, overall serogroups 0.05 and serogroup C/Y/W 0.03; for 18-22 year
olds, overall serogroups 0.20 and serogroup C/Y/W 0.00 per 100,000
population for ABCs areas
National Estimates for Disease ¥ 
Cases: 450 (0.14/100,000)
Deaths: 70 (0.02/100,000)
¥ In 2014, 426 cases of meningococcal disease (all case statuses) were 
reported to the National Notifiable Disease Surveillance System
(incidence 0.13/100,000 population)
Healthy People 2020 Update
Objective: Reduce the incidence of meningococcal
disease to 0.3 per 100,000 population.
2020 Objective 2014 Rate*  
0.3/100,000 
* Per 100,000 U.S. population 
For more information, visit our web site:
 
http://www.cdc.gov/abcs
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